| (a) - (d) | As of the date hereof (i) Corre Opportunities Qualified Master Fund, LP may be deemed to be the beneficial owner of 9,536,514 Shares, constituting 22.2% of the Shares, (ii) Corre Horizon Fund, LP may be deemed to be the beneficial owner of 2,499,430 Shares, constituting 5.8% of the Shares, (iii) Corre Horizon II Fund, LP may be deemed to be the beneficial owner of 2,509,528 Shares, constituting 5.9% of the Shares and (iv) each of the General Partner, the Investment Adviser, Mr. Barrett and Mr. Soderlund may be deemed to be the beneficial owner of 14,545,472 Shares, constituting 33.9% of the Shares, in each case based on 30,980,014 Shares outstanding as of November 8, 2021, as determined based on reports by the Issuer, and after giving effect to the 11,904,761 Shares issued to the Funds pursuant to the Subscription Agreement. Corre Opportunities Qualified Master Fund, LP has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 9,536,514 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 9,536,514 Shares. Corre Horizon Fund, LP has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 2,499,430 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 2,499,430 Shares. Corre Horizon II Fund, LP has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 2,509,528 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 2,509,528 Shares. The General Partner has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 14,545,472 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 14,545,472 Shares. The Investment Adviser has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 14,545,472 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 14,545,472 Shares. Mr. Barrett has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 14,545,472 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 14,545,472 Shares. Mr. Soderlund has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 14,545,472 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 14,545,472 Shares. The Reporting Persons have not, either directly or indirectly, effected any transactions in the Shares since their most recent filing of Schedule 13D. | |
| Item 6 of the Schedule 13D is hereby amended and supplemented as follows: On February 11, 2022, the Funds entered into a common stock subscription agreement (the “Subscription Agreement”) with the Issuer, pursuant to which the Issuer issued and sold 11,904,761 Shares (the “PIPE Shares”) to the Funds at a price of $0.84 per share (the “Equity Issuance”) for an aggregate purchase price of $10.0 million on February 11, 2022.
Pursuant to the Subscription Agreement, subject to certain exceptions, each of the Funds has agreed not to sell its portion of the PIPE Shares until the earliest to occur of (i) the date that is 180 days from the date of the Subscription Agreement, and (ii) such date on which the Issuer completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Issuer’s stockholders having the right to exchange their Shares for cash, securities or other property, without consent of the Issuer.
Pursuant to and subject to the terms and conditions of the Subscription Agreement, the Board of Directors of the Issuer (the “Board”) is required to create a vacancy for one qualified nominee of the Funds to the Board, who shall be designated by the Funds and qualify as an independent director (a “Board Nominee”), and the Board is required to appoint such initial Board Nominee as a Class II director within seven business days of the date of the Subscription Agreement. For so long as the Funds and their affiliates collectively beneficially own at least 10% of the outstanding Shares, pursuant to and subject to the terms and conditions of the Subscription Agreement, the Issuer shall nominate the initial Board Nominee, or a successor Board Nominee chosen by the Funds, for re-election as a Class II director at the first annual meeting of the Issuer’s stockholders to be held after the Equity Issuance and at the end of each subsequent term of such Board Nominee. If at any time, the Funds and their affiliates beneficially own less than 10% of the outstanding Shares, then, if requested by the Issuer, the Board Nominee then on the Board shall resign from his or her directorship, effective as of the Issuer’s next annual meeting of stockholders or such earlier date reasonably requested by the Issuer.
The foregoing summary of the Subscription Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Subscription Agreement, a copy of which is attached hereto as Exhibit B and is incorporated by reference herein.
In connection with the Subscription Agreement, on February 11, 2022, the Issuer, APSC Holdco II, L.P. (“APSC Holdco”) and the Funds entered into that certain Second Amended and Restated Registration Rights Agreement, dated as of February 11, 2022 (the “Second A&R RRA”). Under the terms of the Second A&R RRA, the Issuer is required to prepare and file a resale registration statement with the SEC with respect to the PIPE Shares and certain other Registrable Securities (as defined in the Second A&R RRA) no later than two business days following the earlier of (i) the filing of the Issuer’s Annual Report on Form 10-K for the year ended December 31, 2021 and (ii) April 13, 2022. The Second A&R RRA provides APSC Holdco, Funds and their permitted transferees certain customary demand and piggyback rights with respect to the Registrable Securities, subject to certain terms and conditions set forth therein.
The foregoing summary of the Second A&R RRA does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Second A&R RRA, a copy of which is attached hereto as Exhibit C and is incorporated by reference herein.
As previously announced, on December 8, 2021 the Issuer entered into (i) the Second Amended and Restated Common Stock Purchase Warrant No. 1 (the “Second A&R AP Warrant”) with APSC Holdco, pursuant to which the First Amended and Restated Common Stock Purchase Warrant No. 1 (the “First A&R AP Warrant”) was amended and restated to provide for the purchase of up to 5,000,000 Shares (including 4,082,949 Shares issuable pursuant to the First A&R AP Warrant) exercisable at the holder’s option at any time, in whole or in part, until December 8, 2028, at an exercise price of $1.50 per share, and (ii) the Common Stock Purchase Warrants (together with the Second A&R AP Warrant, the “Warrants”, and individually “Warrant”) with each of the Funds, providing for the purchase of an aggregate of 5,000,000 Shares, exercisable at such holder’s option at any time, in whole or in part, until December 8, 2028, at an exercise price of $1.50 per share.
The foregoing summary of the Warrants does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Warrants, copies of which are attached hereto as Exhibit D, Exhibit E, Exhibit F and Exhibit G and are incorporated by reference herein.
In connection with the Subscription Agreement, on February 11, 2022, the Issuer, the Funds and APSC Holdco entered into those certain Team, Inc. Waivers of Anti-Dilution Adjustments and Cash Transaction Exercise (collectively, the “Warrant Waivers”) with respect to each of the Warrants. Pursuant to the Warrant Waivers, the Funds and APSC Holdco agreed with respect to such holders’ Warrant, subject to certain terms and conditions set forth therein (and for only so long as the applicable provisions remain in effect), among other things, (i) to irrevocably waive certain anti-dilution adjustments set forth in such Warrant in connection with the Proposed Equity Financing (as defined in the Warrant Waivers); (ii) to not exercise such Warrant, in whole or in part, if the Issuer determines that such exercise will cause an ownership change within the meaning of Section 382 of the Internal Revenue Code of 1986, as amended (assuming, among other things, that the ownership change threshold is 47% rather than 50%); and (iii) to only exercise such Warrant in a “cashless” or “net-issue” exercise.
The foregoing summary of the Warrant Waiver does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Warrant Waiver, copies of which are attached hereto as Exhibit H and Exhibit I and are incorporated by reference herein.
In connection with the foregoing transactions, the Issuer entered into (i) the Credit Agreement, dated as of February 11, 2022, among the Issuer, as Borrower, the lenders from time to time party thereto, and Eclipse Business Capital, LLC, as Agent, (ii) Amendment No. 5 to Subordinated Term Loan Credit Agreement, dated February 11, 2022, by and among the Issuer, the lenders party thereto, and Cantor Fitzgerald Securities, as Agent and (iii) Amendment No. 6 to Term Loan Credit Agreement, dated February 11, 2022, among the Issuer, as Borrower, the financial institutions party thereto and Atlantic Park Strategic Capital Fund, L.P., as Agent, the terms of which are described and filed with the Current Report on Form 8-K filed with the SEC by the Issuer on February 15, 2022 and incorporated herein by reference. | |